检索结果 - Shu‐Ching Chen

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Oral Dysfunction in Patients With Head and Neck Cancer: A Systematic Review

    Oral Dysfunction in Patients With Head and Neck Cancer: A Systematic Review 由 Shu‐Ching Chen

    出版 2019
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    The Roles of CD4<sup>+</sup>T Cells in Tumor Immunity

    The Roles of CD4<sup>+</sup>T Cells in Tumor Immunity 由 Yo‐Ping Lai, Chung‐Jiuan Jeng, Shu-Ching Chen

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Nursing Perspectives on the Impacts of COVID-19

    Nursing Perspectives on the Impacts of COVID-19 由 Shu‐Ching Chen, Yeur‐Hur Lai, Shiow‐Luan Tsay

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Nursing Perspectives on the Impacts of COVID-19

    Nursing Perspectives on the Impacts of COVID-19 由 Shu-Ching CHEN, Yeur‐Hur Lai, Shiow‐Luan Tsay

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    The effectiveness of a saline mouth rinse regimen and education programme on radiation-induced oral mucositis and quality of life in oral cavity cancer patients: A randomised controlled trial

    The effectiveness of a saline mouth rinse regimen and education programme on radiation-induced oral mucositis and quality of life in oral cavity cancer patients: A randomised contr... 由 Bing‐Shen Huang, Shu‐Chen Wu, C.Y. Lin, Kang‐Hsing Fan, J. Chang, Shu‐Ching Chen

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Self care behavior in patients with heart failure in Taiwan

    Self care behavior in patients with heart failure in Taiwan 由 Heng‐Hsin Tung, Shu‐Ching Chen, Wei-Hsian Yin, Ching-Hui Cheng, Tsae‐Jyy Wang, Shu‐Fang Vivienne Wu

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    55O_PR Phase III HannaH study of subcutaneous or intravenous trastuzumab for HER2-positive early breast cancer: Exploratory subgroup analyses of pathological complete response and 3-year event-free survival by body weight and anti-drug antibody status

    55O_PR Phase III HannaH study of subcutaneous or intravenous trastuzumab for HER2-positive early breast cancer: Exploratory subgroup analyses of pathological complete response and... 由 Jin Seok Ahn, Christian Jackisch, Roberto Hegg, Daniil Stroyakovskiy, Bohuslav Melichar, Shu‐Ching Chen, A. Crepelle-Fléchais, Sabine Lauer, Mona Shing, Xavier Pivot

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer

    Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer 由 Andrew D. Seidman, Adam Brufsky, Rafat Ansari, Lowell L. Hart, Richard S. Stein, Lee S. Schwartzberg, John F. Stewart, Christy Russell, Shu‐Ching Chen, Luis Fein, Jhony A. De La Cruz‐Vargas, S.-B. Kim, José Antônio Crespo Cavalheiro, Luping Zhao, John F. Gill, Coleman K. Obasaju, Mauro Orlando, D. F. Tai

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: